Medical Care
Global Oligonucleotide Process Development and Manufacturing Market Research Report 2025
- Mar 27, 25
- ID: 159059
- Pages: 91
- Figures: 98
- Views: 42
The global market for Oligonucleotide Process Development and Manufacturing was valued at US$ 1252 million in the year 2024 and is projected to reach a revised size of US$ 2148 million by 2031, growing at a CAGR of 8.3% during the forecast period.
Oligonucleotides are short-chain nucleic acid molecules with extensive applications in gene therapy, vaccine development, and targeted therapies. Oligonucleotide process development involves the optimization of the entire production workflow, from nucleotide monomer synthesis and solid-phase synthesis to purification and final drug formulation, ensuring high purity, high yield, and scalability. Drug manufacturing must comply with Good Manufacturing Practices (GMP), including stringent quality control, sterile environments, and advanced process scale-up technologies to ensure the safety and efficacy of the final product. With the rapid advancement of nucleic acid therapeutics, efficient, cost-effective, and scalable process development is critical for accelerating new drug commercialization.
North American market for Oligonucleotide Process Development and Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oligonucleotide Process Development and Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Oligonucleotide Process Development and Manufacturing in Pharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Oligonucleotide Process Development and Manufacturing include ST Pharm, EUROAPI, Danaher(IDT), Merck, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, Nippon Shokubai, Eurogentec, Ajinomoto Bio-Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide Process Development and Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide Process Development and Manufacturing.
The Oligonucleotide Process Development and Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oligonucleotide Process Development and Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide Process Development and Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ST Pharm
EUROAPI
Danaher(IDT)
Merck
Eurofins Scientific
Thermo Fisher Scientific
Agilent Technologies
Nippon Shokubai
Eurogentec
Ajinomoto Bio-Pharma
PeptiStar
Bachem
CordenPharma
Guangzhou RiboBio
Hongene Biotech
WuXi AppTec
Veliter
Ribobay Pharma
ChemExpress
Asymchem
Segment by Type
Oligonucleotide Process Development
Oligonucleotide Manufacturing
Segment by Application
Pharmaceuticals
Scientific Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotide Process Development and Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Oligonucleotides are short-chain nucleic acid molecules with extensive applications in gene therapy, vaccine development, and targeted therapies. Oligonucleotide process development involves the optimization of the entire production workflow, from nucleotide monomer synthesis and solid-phase synthesis to purification and final drug formulation, ensuring high purity, high yield, and scalability. Drug manufacturing must comply with Good Manufacturing Practices (GMP), including stringent quality control, sterile environments, and advanced process scale-up technologies to ensure the safety and efficacy of the final product. With the rapid advancement of nucleic acid therapeutics, efficient, cost-effective, and scalable process development is critical for accelerating new drug commercialization.
North American market for Oligonucleotide Process Development and Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oligonucleotide Process Development and Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Oligonucleotide Process Development and Manufacturing in Pharmaceuticals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Oligonucleotide Process Development and Manufacturing include ST Pharm, EUROAPI, Danaher(IDT), Merck, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, Nippon Shokubai, Eurogentec, Ajinomoto Bio-Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide Process Development and Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide Process Development and Manufacturing.
The Oligonucleotide Process Development and Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oligonucleotide Process Development and Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide Process Development and Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ST Pharm
EUROAPI
Danaher(IDT)
Merck
Eurofins Scientific
Thermo Fisher Scientific
Agilent Technologies
Nippon Shokubai
Eurogentec
Ajinomoto Bio-Pharma
PeptiStar
Bachem
CordenPharma
Guangzhou RiboBio
Hongene Biotech
WuXi AppTec
Veliter
Ribobay Pharma
ChemExpress
Asymchem
Segment by Type
Oligonucleotide Process Development
Oligonucleotide Manufacturing
Segment by Application
Pharmaceuticals
Scientific Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotide Process Development and Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oligonucleotide Process Development
1.2.3 Oligonucleotide Manufacturing
1.3 Market by Application
1.3.1 Global Oligonucleotide Process Development and Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotide Process Development and Manufacturing Market Perspective (2020-2031)
2.2 Global Oligonucleotide Process Development and Manufacturing Growth Trends by Region
2.2.1 Global Oligonucleotide Process Development and Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oligonucleotide Process Development and Manufacturing Historic Market Size by Region (2020-2025)
2.2.3 Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Region (2026-2031)
2.3 Oligonucleotide Process Development and Manufacturing Market Dynamics
2.3.1 Oligonucleotide Process Development and Manufacturing Industry Trends
2.3.2 Oligonucleotide Process Development and Manufacturing Market Drivers
2.3.3 Oligonucleotide Process Development and Manufacturing Market Challenges
2.3.4 Oligonucleotide Process Development and Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotide Process Development and Manufacturing Players by Revenue
3.1.1 Global Top Oligonucleotide Process Development and Manufacturing Players by Revenue (2020-2025)
3.1.2 Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Players (2020-2025)
3.2 Global Top Oligonucleotide Process Development and Manufacturing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oligonucleotide Process Development and Manufacturing Revenue
3.4 Global Oligonucleotide Process Development and Manufacturing Market Concentration Ratio
3.4.1 Global Oligonucleotide Process Development and Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Process Development and Manufacturing Revenue in 2024
3.5 Global Key Players of Oligonucleotide Process Development and Manufacturing Head office and Area Served
3.6 Global Key Players of Oligonucleotide Process Development and Manufacturing, Product and Application
3.7 Global Key Players of Oligonucleotide Process Development and Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotide Process Development and Manufacturing Breakdown Data by Type
4.1 Global Oligonucleotide Process Development and Manufacturing Historic Market Size by Type (2020-2025)
4.2 Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Type (2026-2031)
5 Oligonucleotide Process Development and Manufacturing Breakdown Data by Application
5.1 Global Oligonucleotide Process Development and Manufacturing Historic Market Size by Application (2020-2025)
5.2 Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)
6.2 North America Oligonucleotide Process Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025)
6.4 North America Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)
7.2 Europe Oligonucleotide Process Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025)
7.4 Europe Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)
8.2 Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size by Region (2020-2025)
8.4 Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)
9.2 Latin America Oligonucleotide Process Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025)
9.4 Latin America Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)
10.2 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025)
10.4 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ST Pharm
11.1.1 ST Pharm Company Details
11.1.2 ST Pharm Business Overview
11.1.3 ST Pharm Oligonucleotide Process Development and Manufacturing Introduction
11.1.4 ST Pharm Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.1.5 ST Pharm Recent Development
11.2 EUROAPI
11.2.1 EUROAPI Company Details
11.2.2 EUROAPI Business Overview
11.2.3 EUROAPI Oligonucleotide Process Development and Manufacturing Introduction
11.2.4 EUROAPI Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.2.5 EUROAPI Recent Development
11.3 Danaher(IDT)
11.3.1 Danaher(IDT) Company Details
11.3.2 Danaher(IDT) Business Overview
11.3.3 Danaher(IDT) Oligonucleotide Process Development and Manufacturing Introduction
11.3.4 Danaher(IDT) Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.3.5 Danaher(IDT) Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Oligonucleotide Process Development and Manufacturing Introduction
11.4.4 Merck Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Oligonucleotide Process Development and Manufacturing Introduction
11.5.4 Eurofins Scientific Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.5.5 Eurofins Scientific Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Oligonucleotide Process Development and Manufacturing Introduction
11.6.4 Thermo Fisher Scientific Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Details
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies Oligonucleotide Process Development and Manufacturing Introduction
11.7.4 Agilent Technologies Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.7.5 Agilent Technologies Recent Development
11.8 Nippon Shokubai
11.8.1 Nippon Shokubai Company Details
11.8.2 Nippon Shokubai Business Overview
11.8.3 Nippon Shokubai Oligonucleotide Process Development and Manufacturing Introduction
11.8.4 Nippon Shokubai Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.8.5 Nippon Shokubai Recent Development
11.9 Eurogentec
11.9.1 Eurogentec Company Details
11.9.2 Eurogentec Business Overview
11.9.3 Eurogentec Oligonucleotide Process Development and Manufacturing Introduction
11.9.4 Eurogentec Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.9.5 Eurogentec Recent Development
11.10 Ajinomoto Bio-Pharma
11.10.1 Ajinomoto Bio-Pharma Company Details
11.10.2 Ajinomoto Bio-Pharma Business Overview
11.10.3 Ajinomoto Bio-Pharma Oligonucleotide Process Development and Manufacturing Introduction
11.10.4 Ajinomoto Bio-Pharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.10.5 Ajinomoto Bio-Pharma Recent Development
11.11 PeptiStar
11.11.1 PeptiStar Company Details
11.11.2 PeptiStar Business Overview
11.11.3 PeptiStar Oligonucleotide Process Development and Manufacturing Introduction
11.11.4 PeptiStar Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.11.5 PeptiStar Recent Development
11.12 Bachem
11.12.1 Bachem Company Details
11.12.2 Bachem Business Overview
11.12.3 Bachem Oligonucleotide Process Development and Manufacturing Introduction
11.12.4 Bachem Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.12.5 Bachem Recent Development
11.13 CordenPharma
11.13.1 CordenPharma Company Details
11.13.2 CordenPharma Business Overview
11.13.3 CordenPharma Oligonucleotide Process Development and Manufacturing Introduction
11.13.4 CordenPharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.13.5 CordenPharma Recent Development
11.14 Guangzhou RiboBio
11.14.1 Guangzhou RiboBio Company Details
11.14.2 Guangzhou RiboBio Business Overview
11.14.3 Guangzhou RiboBio Oligonucleotide Process Development and Manufacturing Introduction
11.14.4 Guangzhou RiboBio Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.14.5 Guangzhou RiboBio Recent Development
11.15 Hongene Biotech
11.15.1 Hongene Biotech Company Details
11.15.2 Hongene Biotech Business Overview
11.15.3 Hongene Biotech Oligonucleotide Process Development and Manufacturing Introduction
11.15.4 Hongene Biotech Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.15.5 Hongene Biotech Recent Development
11.16 WuXi AppTec
11.16.1 WuXi AppTec Company Details
11.16.2 WuXi AppTec Business Overview
11.16.3 WuXi AppTec Oligonucleotide Process Development and Manufacturing Introduction
11.16.4 WuXi AppTec Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.16.5 WuXi AppTec Recent Development
11.17 Veliter
11.17.1 Veliter Company Details
11.17.2 Veliter Business Overview
11.17.3 Veliter Oligonucleotide Process Development and Manufacturing Introduction
11.17.4 Veliter Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.17.5 Veliter Recent Development
11.18 Ribobay Pharma
11.18.1 Ribobay Pharma Company Details
11.18.2 Ribobay Pharma Business Overview
11.18.3 Ribobay Pharma Oligonucleotide Process Development and Manufacturing Introduction
11.18.4 Ribobay Pharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.18.5 Ribobay Pharma Recent Development
11.19 ChemExpress
11.19.1 ChemExpress Company Details
11.19.2 ChemExpress Business Overview
11.19.3 ChemExpress Oligonucleotide Process Development and Manufacturing Introduction
11.19.4 ChemExpress Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.19.5 ChemExpress Recent Development
11.20 Asymchem
11.20.1 Asymchem Company Details
11.20.2 Asymchem Business Overview
11.20.3 Asymchem Oligonucleotide Process Development and Manufacturing Introduction
11.20.4 Asymchem Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.20.5 Asymchem Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oligonucleotide Process Development
1.2.3 Oligonucleotide Manufacturing
1.3 Market by Application
1.3.1 Global Oligonucleotide Process Development and Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotide Process Development and Manufacturing Market Perspective (2020-2031)
2.2 Global Oligonucleotide Process Development and Manufacturing Growth Trends by Region
2.2.1 Global Oligonucleotide Process Development and Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oligonucleotide Process Development and Manufacturing Historic Market Size by Region (2020-2025)
2.2.3 Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Region (2026-2031)
2.3 Oligonucleotide Process Development and Manufacturing Market Dynamics
2.3.1 Oligonucleotide Process Development and Manufacturing Industry Trends
2.3.2 Oligonucleotide Process Development and Manufacturing Market Drivers
2.3.3 Oligonucleotide Process Development and Manufacturing Market Challenges
2.3.4 Oligonucleotide Process Development and Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotide Process Development and Manufacturing Players by Revenue
3.1.1 Global Top Oligonucleotide Process Development and Manufacturing Players by Revenue (2020-2025)
3.1.2 Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Players (2020-2025)
3.2 Global Top Oligonucleotide Process Development and Manufacturing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oligonucleotide Process Development and Manufacturing Revenue
3.4 Global Oligonucleotide Process Development and Manufacturing Market Concentration Ratio
3.4.1 Global Oligonucleotide Process Development and Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Process Development and Manufacturing Revenue in 2024
3.5 Global Key Players of Oligonucleotide Process Development and Manufacturing Head office and Area Served
3.6 Global Key Players of Oligonucleotide Process Development and Manufacturing, Product and Application
3.7 Global Key Players of Oligonucleotide Process Development and Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotide Process Development and Manufacturing Breakdown Data by Type
4.1 Global Oligonucleotide Process Development and Manufacturing Historic Market Size by Type (2020-2025)
4.2 Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Type (2026-2031)
5 Oligonucleotide Process Development and Manufacturing Breakdown Data by Application
5.1 Global Oligonucleotide Process Development and Manufacturing Historic Market Size by Application (2020-2025)
5.2 Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)
6.2 North America Oligonucleotide Process Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025)
6.4 North America Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)
7.2 Europe Oligonucleotide Process Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025)
7.4 Europe Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)
8.2 Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size by Region (2020-2025)
8.4 Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)
9.2 Latin America Oligonucleotide Process Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025)
9.4 Latin America Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size (2020-2031)
10.2 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025)
10.4 Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ST Pharm
11.1.1 ST Pharm Company Details
11.1.2 ST Pharm Business Overview
11.1.3 ST Pharm Oligonucleotide Process Development and Manufacturing Introduction
11.1.4 ST Pharm Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.1.5 ST Pharm Recent Development
11.2 EUROAPI
11.2.1 EUROAPI Company Details
11.2.2 EUROAPI Business Overview
11.2.3 EUROAPI Oligonucleotide Process Development and Manufacturing Introduction
11.2.4 EUROAPI Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.2.5 EUROAPI Recent Development
11.3 Danaher(IDT)
11.3.1 Danaher(IDT) Company Details
11.3.2 Danaher(IDT) Business Overview
11.3.3 Danaher(IDT) Oligonucleotide Process Development and Manufacturing Introduction
11.3.4 Danaher(IDT) Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.3.5 Danaher(IDT) Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Oligonucleotide Process Development and Manufacturing Introduction
11.4.4 Merck Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Oligonucleotide Process Development and Manufacturing Introduction
11.5.4 Eurofins Scientific Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.5.5 Eurofins Scientific Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Oligonucleotide Process Development and Manufacturing Introduction
11.6.4 Thermo Fisher Scientific Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Details
11.7.2 Agilent Technologies Business Overview
11.7.3 Agilent Technologies Oligonucleotide Process Development and Manufacturing Introduction
11.7.4 Agilent Technologies Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.7.5 Agilent Technologies Recent Development
11.8 Nippon Shokubai
11.8.1 Nippon Shokubai Company Details
11.8.2 Nippon Shokubai Business Overview
11.8.3 Nippon Shokubai Oligonucleotide Process Development and Manufacturing Introduction
11.8.4 Nippon Shokubai Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.8.5 Nippon Shokubai Recent Development
11.9 Eurogentec
11.9.1 Eurogentec Company Details
11.9.2 Eurogentec Business Overview
11.9.3 Eurogentec Oligonucleotide Process Development and Manufacturing Introduction
11.9.4 Eurogentec Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.9.5 Eurogentec Recent Development
11.10 Ajinomoto Bio-Pharma
11.10.1 Ajinomoto Bio-Pharma Company Details
11.10.2 Ajinomoto Bio-Pharma Business Overview
11.10.3 Ajinomoto Bio-Pharma Oligonucleotide Process Development and Manufacturing Introduction
11.10.4 Ajinomoto Bio-Pharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.10.5 Ajinomoto Bio-Pharma Recent Development
11.11 PeptiStar
11.11.1 PeptiStar Company Details
11.11.2 PeptiStar Business Overview
11.11.3 PeptiStar Oligonucleotide Process Development and Manufacturing Introduction
11.11.4 PeptiStar Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.11.5 PeptiStar Recent Development
11.12 Bachem
11.12.1 Bachem Company Details
11.12.2 Bachem Business Overview
11.12.3 Bachem Oligonucleotide Process Development and Manufacturing Introduction
11.12.4 Bachem Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.12.5 Bachem Recent Development
11.13 CordenPharma
11.13.1 CordenPharma Company Details
11.13.2 CordenPharma Business Overview
11.13.3 CordenPharma Oligonucleotide Process Development and Manufacturing Introduction
11.13.4 CordenPharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.13.5 CordenPharma Recent Development
11.14 Guangzhou RiboBio
11.14.1 Guangzhou RiboBio Company Details
11.14.2 Guangzhou RiboBio Business Overview
11.14.3 Guangzhou RiboBio Oligonucleotide Process Development and Manufacturing Introduction
11.14.4 Guangzhou RiboBio Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.14.5 Guangzhou RiboBio Recent Development
11.15 Hongene Biotech
11.15.1 Hongene Biotech Company Details
11.15.2 Hongene Biotech Business Overview
11.15.3 Hongene Biotech Oligonucleotide Process Development and Manufacturing Introduction
11.15.4 Hongene Biotech Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.15.5 Hongene Biotech Recent Development
11.16 WuXi AppTec
11.16.1 WuXi AppTec Company Details
11.16.2 WuXi AppTec Business Overview
11.16.3 WuXi AppTec Oligonucleotide Process Development and Manufacturing Introduction
11.16.4 WuXi AppTec Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.16.5 WuXi AppTec Recent Development
11.17 Veliter
11.17.1 Veliter Company Details
11.17.2 Veliter Business Overview
11.17.3 Veliter Oligonucleotide Process Development and Manufacturing Introduction
11.17.4 Veliter Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.17.5 Veliter Recent Development
11.18 Ribobay Pharma
11.18.1 Ribobay Pharma Company Details
11.18.2 Ribobay Pharma Business Overview
11.18.3 Ribobay Pharma Oligonucleotide Process Development and Manufacturing Introduction
11.18.4 Ribobay Pharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.18.5 Ribobay Pharma Recent Development
11.19 ChemExpress
11.19.1 ChemExpress Company Details
11.19.2 ChemExpress Business Overview
11.19.3 ChemExpress Oligonucleotide Process Development and Manufacturing Introduction
11.19.4 ChemExpress Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.19.5 ChemExpress Recent Development
11.20 Asymchem
11.20.1 Asymchem Company Details
11.20.2 Asymchem Business Overview
11.20.3 Asymchem Oligonucleotide Process Development and Manufacturing Introduction
11.20.4 Asymchem Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
11.20.5 Asymchem Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oligonucleotide Process Development
Table 3. Key Players of Oligonucleotide Manufacturing
Table 4. Global Oligonucleotide Process Development and Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Oligonucleotide Process Development and Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Oligonucleotide Process Development and Manufacturing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Oligonucleotide Process Development and Manufacturing Market Share by Region (2020-2025)
Table 8. Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Oligonucleotide Process Development and Manufacturing Market Share by Region (2026-2031)
Table 10. Oligonucleotide Process Development and Manufacturing Market Trends
Table 11. Oligonucleotide Process Development and Manufacturing Market Drivers
Table 12. Oligonucleotide Process Development and Manufacturing Market Challenges
Table 13. Oligonucleotide Process Development and Manufacturing Market Restraints
Table 14. Global Oligonucleotide Process Development and Manufacturing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Oligonucleotide Process Development and Manufacturing Market Share by Players (2020-2025)
Table 16. Global Top Oligonucleotide Process Development and Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Process Development and Manufacturing as of 2024)
Table 17. Ranking of Global Top Oligonucleotide Process Development and Manufacturing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Oligonucleotide Process Development and Manufacturing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Oligonucleotide Process Development and Manufacturing, Headquarters and Area Served
Table 20. Global Key Players of Oligonucleotide Process Development and Manufacturing, Product and Application
Table 21. Global Key Players of Oligonucleotide Process Development and Manufacturing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oligonucleotide Process Development and Manufacturing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Type (2020-2025)
Table 25. Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Type (2026-2031)
Table 27. Global Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Application (2020-2025)
Table 29. Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Application (2026-2031)
Table 31. North America Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)
Table 46. ST Pharm Company Details
Table 47. ST Pharm Business Overview
Table 48. ST Pharm Oligonucleotide Process Development and Manufacturing Product
Table 49. ST Pharm Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 50. ST Pharm Recent Development
Table 51. EUROAPI Company Details
Table 52. EUROAPI Business Overview
Table 53. EUROAPI Oligonucleotide Process Development and Manufacturing Product
Table 54. EUROAPI Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 55. EUROAPI Recent Development
Table 56. Danaher(IDT) Company Details
Table 57. Danaher(IDT) Business Overview
Table 58. Danaher(IDT) Oligonucleotide Process Development and Manufacturing Product
Table 59. Danaher(IDT) Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 60. Danaher(IDT) Recent Development
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Oligonucleotide Process Development and Manufacturing Product
Table 64. Merck Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Eurofins Scientific Company Details
Table 67. Eurofins Scientific Business Overview
Table 68. Eurofins Scientific Oligonucleotide Process Development and Manufacturing Product
Table 69. Eurofins Scientific Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 70. Eurofins Scientific Recent Development
Table 71. Thermo Fisher Scientific Company Details
Table 72. Thermo Fisher Scientific Business Overview
Table 73. Thermo Fisher Scientific Oligonucleotide Process Development and Manufacturing Product
Table 74. Thermo Fisher Scientific Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 75. Thermo Fisher Scientific Recent Development
Table 76. Agilent Technologies Company Details
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies Oligonucleotide Process Development and Manufacturing Product
Table 79. Agilent Technologies Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 80. Agilent Technologies Recent Development
Table 81. Nippon Shokubai Company Details
Table 82. Nippon Shokubai Business Overview
Table 83. Nippon Shokubai Oligonucleotide Process Development and Manufacturing Product
Table 84. Nippon Shokubai Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 85. Nippon Shokubai Recent Development
Table 86. Eurogentec Company Details
Table 87. Eurogentec Business Overview
Table 88. Eurogentec Oligonucleotide Process Development and Manufacturing Product
Table 89. Eurogentec Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 90. Eurogentec Recent Development
Table 91. Ajinomoto Bio-Pharma Company Details
Table 92. Ajinomoto Bio-Pharma Business Overview
Table 93. Ajinomoto Bio-Pharma Oligonucleotide Process Development and Manufacturing Product
Table 94. Ajinomoto Bio-Pharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 95. Ajinomoto Bio-Pharma Recent Development
Table 96. PeptiStar Company Details
Table 97. PeptiStar Business Overview
Table 98. PeptiStar Oligonucleotide Process Development and Manufacturing Product
Table 99. PeptiStar Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 100. PeptiStar Recent Development
Table 101. Bachem Company Details
Table 102. Bachem Business Overview
Table 103. Bachem Oligonucleotide Process Development and Manufacturing Product
Table 104. Bachem Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 105. Bachem Recent Development
Table 106. CordenPharma Company Details
Table 107. CordenPharma Business Overview
Table 108. CordenPharma Oligonucleotide Process Development and Manufacturing Product
Table 109. CordenPharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 110. CordenPharma Recent Development
Table 111. Guangzhou RiboBio Company Details
Table 112. Guangzhou RiboBio Business Overview
Table 113. Guangzhou RiboBio Oligonucleotide Process Development and Manufacturing Product
Table 114. Guangzhou RiboBio Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 115. Guangzhou RiboBio Recent Development
Table 116. Hongene Biotech Company Details
Table 117. Hongene Biotech Business Overview
Table 118. Hongene Biotech Oligonucleotide Process Development and Manufacturing Product
Table 119. Hongene Biotech Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 120. Hongene Biotech Recent Development
Table 121. WuXi AppTec Company Details
Table 122. WuXi AppTec Business Overview
Table 123. WuXi AppTec Oligonucleotide Process Development and Manufacturing Product
Table 124. WuXi AppTec Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 125. WuXi AppTec Recent Development
Table 126. Veliter Company Details
Table 127. Veliter Business Overview
Table 128. Veliter Oligonucleotide Process Development and Manufacturing Product
Table 129. Veliter Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 130. Veliter Recent Development
Table 131. Ribobay Pharma Company Details
Table 132. Ribobay Pharma Business Overview
Table 133. Ribobay Pharma Oligonucleotide Process Development and Manufacturing Product
Table 134. Ribobay Pharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 135. Ribobay Pharma Recent Development
Table 136. ChemExpress Company Details
Table 137. ChemExpress Business Overview
Table 138. ChemExpress Oligonucleotide Process Development and Manufacturing Product
Table 139. ChemExpress Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 140. ChemExpress Recent Development
Table 141. Asymchem Company Details
Table 142. Asymchem Business Overview
Table 143. Asymchem Oligonucleotide Process Development and Manufacturing Product
Table 144. Asymchem Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 145. Asymchem Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 149. Authors List of This Report
List of Figures
Figure 1. Oligonucleotide Process Development and Manufacturing Picture
Figure 2. Global Oligonucleotide Process Development and Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oligonucleotide Process Development and Manufacturing Market Share by Type: 2024 VS 2031
Figure 4. Oligonucleotide Process Development Features
Figure 5. Oligonucleotide Manufacturing Features
Figure 6. Global Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Oligonucleotide Process Development and Manufacturing Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceuticals Case Studies
Figure 9. Scientific Research Case Studies
Figure 10. Oligonucleotide Process Development and Manufacturing Report Years Considered
Figure 11. Global Oligonucleotide Process Development and Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Oligonucleotide Process Development and Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Oligonucleotide Process Development and Manufacturing Market Share by Region: 2024 VS 2031
Figure 14. Global Oligonucleotide Process Development and Manufacturing Market Share by Players in 2024
Figure 15. Global Oligonucleotide Process Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Oligonucleotide Process Development and Manufacturing Revenue in 2024
Figure 17. North America Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Oligonucleotide Process Development and Manufacturing Market Share by Country (2020-2031)
Figure 19. United States Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Oligonucleotide Process Development and Manufacturing Market Share by Country (2020-2031)
Figure 23. Germany Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Share by Region (2020-2031)
Figure 31. China Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Oligonucleotide Process Development and Manufacturing Market Share by Country (2020-2031)
Figure 39. Mexico Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Share by Country (2020-2031)
Figure 43. Turkey Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. ST Pharm Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 47. EUROAPI Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 48. Danaher(IDT) Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 49. Merck Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 50. Eurofins Scientific Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 52. Agilent Technologies Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 53. Nippon Shokubai Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 54. Eurogentec Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 55. Ajinomoto Bio-Pharma Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 56. PeptiStar Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 57. Bachem Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 58. CordenPharma Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 59. Guangzhou RiboBio Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 60. Hongene Biotech Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 61. WuXi AppTec Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 62. Veliter Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 63. Ribobay Pharma Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 64. ChemExpress Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 65. Asymchem Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oligonucleotide Process Development
Table 3. Key Players of Oligonucleotide Manufacturing
Table 4. Global Oligonucleotide Process Development and Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Oligonucleotide Process Development and Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Oligonucleotide Process Development and Manufacturing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Oligonucleotide Process Development and Manufacturing Market Share by Region (2020-2025)
Table 8. Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Oligonucleotide Process Development and Manufacturing Market Share by Region (2026-2031)
Table 10. Oligonucleotide Process Development and Manufacturing Market Trends
Table 11. Oligonucleotide Process Development and Manufacturing Market Drivers
Table 12. Oligonucleotide Process Development and Manufacturing Market Challenges
Table 13. Oligonucleotide Process Development and Manufacturing Market Restraints
Table 14. Global Oligonucleotide Process Development and Manufacturing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Oligonucleotide Process Development and Manufacturing Market Share by Players (2020-2025)
Table 16. Global Top Oligonucleotide Process Development and Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Process Development and Manufacturing as of 2024)
Table 17. Ranking of Global Top Oligonucleotide Process Development and Manufacturing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Oligonucleotide Process Development and Manufacturing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Oligonucleotide Process Development and Manufacturing, Headquarters and Area Served
Table 20. Global Key Players of Oligonucleotide Process Development and Manufacturing, Product and Application
Table 21. Global Key Players of Oligonucleotide Process Development and Manufacturing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oligonucleotide Process Development and Manufacturing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Type (2020-2025)
Table 25. Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Type (2026-2031)
Table 27. Global Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Application (2020-2025)
Table 29. Global Oligonucleotide Process Development and Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Oligonucleotide Process Development and Manufacturing Revenue Market Share by Application (2026-2031)
Table 31. North America Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)
Table 46. ST Pharm Company Details
Table 47. ST Pharm Business Overview
Table 48. ST Pharm Oligonucleotide Process Development and Manufacturing Product
Table 49. ST Pharm Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 50. ST Pharm Recent Development
Table 51. EUROAPI Company Details
Table 52. EUROAPI Business Overview
Table 53. EUROAPI Oligonucleotide Process Development and Manufacturing Product
Table 54. EUROAPI Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 55. EUROAPI Recent Development
Table 56. Danaher(IDT) Company Details
Table 57. Danaher(IDT) Business Overview
Table 58. Danaher(IDT) Oligonucleotide Process Development and Manufacturing Product
Table 59. Danaher(IDT) Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 60. Danaher(IDT) Recent Development
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Oligonucleotide Process Development and Manufacturing Product
Table 64. Merck Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Eurofins Scientific Company Details
Table 67. Eurofins Scientific Business Overview
Table 68. Eurofins Scientific Oligonucleotide Process Development and Manufacturing Product
Table 69. Eurofins Scientific Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 70. Eurofins Scientific Recent Development
Table 71. Thermo Fisher Scientific Company Details
Table 72. Thermo Fisher Scientific Business Overview
Table 73. Thermo Fisher Scientific Oligonucleotide Process Development and Manufacturing Product
Table 74. Thermo Fisher Scientific Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 75. Thermo Fisher Scientific Recent Development
Table 76. Agilent Technologies Company Details
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies Oligonucleotide Process Development and Manufacturing Product
Table 79. Agilent Technologies Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 80. Agilent Technologies Recent Development
Table 81. Nippon Shokubai Company Details
Table 82. Nippon Shokubai Business Overview
Table 83. Nippon Shokubai Oligonucleotide Process Development and Manufacturing Product
Table 84. Nippon Shokubai Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 85. Nippon Shokubai Recent Development
Table 86. Eurogentec Company Details
Table 87. Eurogentec Business Overview
Table 88. Eurogentec Oligonucleotide Process Development and Manufacturing Product
Table 89. Eurogentec Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 90. Eurogentec Recent Development
Table 91. Ajinomoto Bio-Pharma Company Details
Table 92. Ajinomoto Bio-Pharma Business Overview
Table 93. Ajinomoto Bio-Pharma Oligonucleotide Process Development and Manufacturing Product
Table 94. Ajinomoto Bio-Pharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 95. Ajinomoto Bio-Pharma Recent Development
Table 96. PeptiStar Company Details
Table 97. PeptiStar Business Overview
Table 98. PeptiStar Oligonucleotide Process Development and Manufacturing Product
Table 99. PeptiStar Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 100. PeptiStar Recent Development
Table 101. Bachem Company Details
Table 102. Bachem Business Overview
Table 103. Bachem Oligonucleotide Process Development and Manufacturing Product
Table 104. Bachem Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 105. Bachem Recent Development
Table 106. CordenPharma Company Details
Table 107. CordenPharma Business Overview
Table 108. CordenPharma Oligonucleotide Process Development and Manufacturing Product
Table 109. CordenPharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 110. CordenPharma Recent Development
Table 111. Guangzhou RiboBio Company Details
Table 112. Guangzhou RiboBio Business Overview
Table 113. Guangzhou RiboBio Oligonucleotide Process Development and Manufacturing Product
Table 114. Guangzhou RiboBio Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 115. Guangzhou RiboBio Recent Development
Table 116. Hongene Biotech Company Details
Table 117. Hongene Biotech Business Overview
Table 118. Hongene Biotech Oligonucleotide Process Development and Manufacturing Product
Table 119. Hongene Biotech Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 120. Hongene Biotech Recent Development
Table 121. WuXi AppTec Company Details
Table 122. WuXi AppTec Business Overview
Table 123. WuXi AppTec Oligonucleotide Process Development and Manufacturing Product
Table 124. WuXi AppTec Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 125. WuXi AppTec Recent Development
Table 126. Veliter Company Details
Table 127. Veliter Business Overview
Table 128. Veliter Oligonucleotide Process Development and Manufacturing Product
Table 129. Veliter Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 130. Veliter Recent Development
Table 131. Ribobay Pharma Company Details
Table 132. Ribobay Pharma Business Overview
Table 133. Ribobay Pharma Oligonucleotide Process Development and Manufacturing Product
Table 134. Ribobay Pharma Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 135. Ribobay Pharma Recent Development
Table 136. ChemExpress Company Details
Table 137. ChemExpress Business Overview
Table 138. ChemExpress Oligonucleotide Process Development and Manufacturing Product
Table 139. ChemExpress Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 140. ChemExpress Recent Development
Table 141. Asymchem Company Details
Table 142. Asymchem Business Overview
Table 143. Asymchem Oligonucleotide Process Development and Manufacturing Product
Table 144. Asymchem Revenue in Oligonucleotide Process Development and Manufacturing Business (2020-2025) & (US$ Million)
Table 145. Asymchem Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 149. Authors List of This Report
List of Figures
Figure 1. Oligonucleotide Process Development and Manufacturing Picture
Figure 2. Global Oligonucleotide Process Development and Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oligonucleotide Process Development and Manufacturing Market Share by Type: 2024 VS 2031
Figure 4. Oligonucleotide Process Development Features
Figure 5. Oligonucleotide Manufacturing Features
Figure 6. Global Oligonucleotide Process Development and Manufacturing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Oligonucleotide Process Development and Manufacturing Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceuticals Case Studies
Figure 9. Scientific Research Case Studies
Figure 10. Oligonucleotide Process Development and Manufacturing Report Years Considered
Figure 11. Global Oligonucleotide Process Development and Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Oligonucleotide Process Development and Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Oligonucleotide Process Development and Manufacturing Market Share by Region: 2024 VS 2031
Figure 14. Global Oligonucleotide Process Development and Manufacturing Market Share by Players in 2024
Figure 15. Global Oligonucleotide Process Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Oligonucleotide Process Development and Manufacturing Revenue in 2024
Figure 17. North America Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Oligonucleotide Process Development and Manufacturing Market Share by Country (2020-2031)
Figure 19. United States Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Oligonucleotide Process Development and Manufacturing Market Share by Country (2020-2031)
Figure 23. Germany Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Oligonucleotide Process Development and Manufacturing Market Share by Region (2020-2031)
Figure 31. China Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Oligonucleotide Process Development and Manufacturing Market Share by Country (2020-2031)
Figure 39. Mexico Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Oligonucleotide Process Development and Manufacturing Market Share by Country (2020-2031)
Figure 43. Turkey Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Oligonucleotide Process Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. ST Pharm Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 47. EUROAPI Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 48. Danaher(IDT) Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 49. Merck Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 50. Eurofins Scientific Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 52. Agilent Technologies Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 53. Nippon Shokubai Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 54. Eurogentec Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 55. Ajinomoto Bio-Pharma Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 56. PeptiStar Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 57. Bachem Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 58. CordenPharma Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 59. Guangzhou RiboBio Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 60. Hongene Biotech Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 61. WuXi AppTec Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 62. Veliter Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 63. Ribobay Pharma Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 64. ChemExpress Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 65. Asymchem Revenue Growth Rate in Oligonucleotide Process Development and Manufacturing Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232